Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study

References

• Lagune M, Petit C, Sotomayor FV, et al. Conserved and specialized functions of type VII secretion systems in non-tuberculous mycobacteria. Microbiology. 2021;167(7):001054.
   Web of Science ®Google Scholar
• Gopalaswamy R, Shanmugam S, Mondal R, et al. Of tuberculosis and non-tuberculous mycobacterial infections–a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020;27(1):1–7.
   PubMed Web of Science ®Google Scholar
• Nasiri MJ, Dabiri H, Darban-Sarokhalil D, et al. Prevalence of non-tuberculosis mycobacterial infections among tuberculosis suspects in Iran: systematic review and meta-analysis. PloS One. 2015;10(6):e0129073.
   PubMed Web of Science ®Google Scholar
• Nasiri MJ, Dabiri H, Fooladi AAI, et al. High rates of nontuberculous mycobacteria isolation from patients with presumptive tuberculosis in Iran. New Microbes New Infect. 2018;21:12–17.
   PubMedGoogle Scholar
• Hashemi Shahraki A, Heidarieh P, Zaker Bostanabad S, et al. Multidrug-resistant tuberculosis may be nontuberculous mycobacteria. Eur J Intern Med. 2015;26:279–284.
   PubMed Web of Science ®Google Scholar
• Ratnatunga CN, Lutzky VP, Kupz A, et al. The rise of non-tuberculosis mycobacterial lung disease. Front Immunol. 2020;11:303.
   PubMed Web of Science ®Google Scholar
• Saxena S, Spaink HP, Forn-Cuní G. Drug resistance in nontuberculous mycobacteria: mechanisms and models. Biology (Basel). 2021;10(2):96.
   PubMedGoogle Scholar
• Bento CM, Gomes MS, Silva T. Looking beyond typical treatments for atypical mycobacteria. Antibiotics (Basel). 2020;9(1):18.
   PubMed Web of Science ®Google Scholar
• Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1–64.
   PubMedGoogle Scholar
• Park H-E, Kim S, Shim S, et al. 16S and 23S rRNA gene mutation independent multidrug resistance of non-tuberculous mycobacteria isolated from South Korean Soil. Microorganisms. 2020;8(8):1114.
   PubMed Web of Science ®Google Scholar
• Nasiri MJ, Haeili M, Ghazi M, et al. New insights in to the intrinsic and acquired drug resistance mechanisms in mycobacteria. Front Microbiol. 2017;8:681.
   PubMed Web of Science ®Google Scholar
• Huh HJ, Kim S-Y, Jhun BW, et al. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases. Infect Genet Evol. 2019;72:169–182.
   PubMed Web of Science ®Google Scholar
• Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020;71(4):e1–36.
   PubMed Web of Science ®Google Scholar
• Mohammadi S, Esfahani BN, Moghim S, et al. Optimal DNA isolation method for detection of nontuberculous mycobacteria by polymerase chain reaction. Adv Biomed Res. 2017;6:133.
   PubMedGoogle Scholar
• Dai J, Chen Y, Dean S, et al. Multiple-genome comparison reveals new loci for mycobacterium species identification. J Clin Microbiol. 2011;49(1):144–153.
   PubMed Web of Science ®Google Scholar
• Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731–2739.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. In: CLSI standard document M24-A2. 2rd ed. Wayne PA: Clinical and Laboratory Standards Institute; 2011 20–25. .
   Google Scholar
• Pang H, Jiang Y, Wan K. Drug susceptibility of 33 reference strains of slowly growing mycobacteria to 19 antimicrobial agents. BioMed Res Int. 2017;2017:1584658.
   PubMed Web of Science ®Google Scholar
• Araj GF, Baba OZ, Itani LY, et al. Non-tuberculous mycobacteria profiles and their anti-mycobacterial resistance at a major medical center in Lebanon. J Infect Dev Ctries. 2019;13(7):612–618.
   PubMed Web of Science ®Google Scholar
• Bakuła Z, Modrzejewska M, Pennings L, et al. Drug susceptibility profiling and genetic determinants of drug resistance in mycobacterium kansasii. Antimicrob Agents Chemother. 2018;62(4):e01788–17.
   PubMed Web of Science ®Google Scholar
• Shen Y, Wang X, Jin J, et al. In vitro susceptibility of mycobacterium abscessus and mycobacterium fortuitum isolates to 30 antibiotics. BioMed Res Int. 2018;2018:4902941.
   PubMed Web of Science ®Google Scholar
• Karami-Zarandi M, Bahador A, Gizaw Feysia S, et al. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients. Arch Razi Inst. 2019;74(4):375–384.
   PubMedGoogle Scholar
• Krishnan MY, Manning EJ, Collins MT. Comparison of three methods for susceptibility testing of mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs. J Antimicrob Chemother. 2009;64(2):310–316.
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.
   PubMed Web of Science ®Google Scholar
• Falkinham JO. Challenges of NTM drug development. Front Microbiol. 2018;9:1613.
   PubMed Web of Science ®Google Scholar
• Khan ZA, Siddiqui MF, Park S. Current and emerging methods of antibiotic susceptibility testing. Diagnostics (Basel). 2019;9(2):49.
   PubMedGoogle Scholar
• Liu CF, Song YM, He WC, et al. Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. Infect Dis Poverty. 2021;10:59.
   PubMed Web of Science ®Google Scholar
• Wetzstein N, Kohl TA, Andres S, et al. Comparative analysis of phenotypic and genotypic antibiotic susceptibility patterns in mycobacterium avium complex. Int J Infect Dis. 2020;93:320–328.
   PubMed Web of Science ®Google Scholar
• Otchere ID, Asante-Poku A, Osei-Wusu S, et al. Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana. Int J Mycobacteriol. 2017;6(1):70–75.
   PubMed Web of Science ®Google Scholar
• Heidarieh P, Mirsaeidi M, Hashemzadeh M, et al. In vitro antimicrobial susceptibility of nontuberculous mycobacteria in Iran. Microb Drug Resist. 2016;22(2):172–178.
   PubMed Web of Science ®Google Scholar
• Brown-Elliott BA, Woods GL. Antimycobacterial susceptibility testing of nontuberculous mycobacteria. J Clin Microbiol. 2019;57(10):e00834–19.
   PubMed Web of Science ®Google Scholar
• Luo J, Yu X, Jiang G, et al. In vitro activity of CFZ against nontuberculous mycobacteria isolated in Beijing, China. Antimicrob Agents Chemother. 2018;62(7):e00072–18.
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhao H, Yuan H, et al. Prevalence and antimicrobial susceptibility of non-tuberculous mycobacteria isolated from sputum samples of patients with pulmonary infections in China. Jundishapur J Microbiol. 2021;14(1):e109676.
   Web of Science ®Google Scholar
• Daley CL, Winthrop KL. Mycobacterium avium complex: addressing gaps in diagnosis and management. J Infect Dis. 2020;222(Supplement_4):S199–211.
   PubMedGoogle Scholar
• Huh HJ, Kim SY, Shim HJ, et al. GenoType NTM-DR performance evaluation for identification of mycobacterium avium complex and mycobacterium abscessus and determination of clarithromycin and amikacin resistance. J Clin Microbiol. 2019;57(8):e00516–19.
   PubMed Web of Science ®Google Scholar
• Lotfi H, Aryan E, Sankian M, et al. A case of multidrug-resistant mycobacterium simiae in an elderly woman. Respirol Case Rep. 2021;9(3):e00715.
   PubMed Web of Science ®Google Scholar
• De Moura VC, Da Silva MG, Gomes KM, et al. Phenotypic and molecular characterization of quinolone resistance in mycobacterium abscessus subsp. bolletii recovered from postsurgical infections. J Med Microbiol. 2012;61(1):115–125.
   PubMed Web of Science ®Google Scholar
• Rindi L. Efflux pump inhibitors against nontuberculous mycobacteria. Int J Mol Sci. 2020;21(12):4191 .
   PubMed Web of Science ®Google Scholar
• Hoza AS, Mfinanga SG, Rodloff AC, et al. Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes. BMC Res Notes. 2016;9:109.
   PubMedGoogle Scholar